Kevin R. Sayer - Mar 1, 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Signature
By: Jereme Sylvain For: Kevin Sayer
Stock symbol
DXCM
Transactions as of
Mar 1, 2023
Transactions value $
-$4,228,611
Form type
4
Date filed
3/2/2023, 04:16 PM
Previous filing
Jan 31, 2023
Next filing
Mar 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$3.43M -31.2K -8.44% $109.83 339K Mar 1, 2023 Direct F1, F2, F3
transaction DXCM Common Stock Sale -$802K -7.26K -2.14% $110.41 331K Mar 1, 2023 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 1, 2022, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2 This transaction was executed in multiple trades at prices ranging from $109.41 to $110.28. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 Included in this number are 134,792 unvested restricted stock units, 65,004 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 35,852 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 33,936 of which were granted on March 8, 2020 and shall vest through March 8, 2023.
F4 This transaction was executed in multiple trades at prices ranging from $110.31 to $110.51. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.